Review: Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies
出版年份 2009 全文链接
标题
Review: Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies
作者
关键词
-
出版物
Therapeutic Advances in Gastroenterology
Volume 3, Issue 1, Pages 55-66
出版商
SAGE Publications
发表日期
2009-10-06
DOI
10.1177/1756283x09346669
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials
- (2009) Ambrogio Orlando et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma
- (2009) Wei-Ping Zhou et al. ANNALS OF SURGERY
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
- (2009) Hung Huynh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
- (2009) Antonius A. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
- (2009) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis
- (2009) M. Pinter et al. ONCOLOGIST
- Effect of Low-Dose Rapamycin on Tumor Growth in Two Human Hepatocellular Cancer Cell Lines
- (2009) M. Heuer et al. TRANSPLANTATION PROCEEDINGS
- Molecular profiling to predict hepatocellular carcinoma outcome
- (2009) Yujin Hoshida et al. Expert Review of Gastroenterology & Hepatology
- Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria
- (2008) F. Y. Yao AMERICAN JOURNAL OF TRANSPLANTATION
- Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma
- (2008) Amani Asnacios et al. CANCER
- Gene Expression-Based Recurrence Prediction of Hepatitis B Virus-Related Human Hepatocellular Carcinoma
- (2008) H. G. Woo et al. CLINICAL CANCER RESEARCH
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
- (2008) Francis Y. Yao et al. HEPATOLOGY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
- (2008) Michael A. Zimmerman et al. LIVER TRANSPLANTATION
- Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
- (2008) Sung-Gyu Lee et al. LIVER TRANSPLANTATION
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
- University of California at San Francisco Criteria Can Be Applied to Living Donor Liver Transplantation for Hepatocellular Carcinoma: Single-Center Preliminary Results in 27 Patients
- (2008) X.-Z. Jiang et al. TRANSPLANTATION PROCEEDINGS
- Sirolimus Therapy in Liver Transplant Patients: An Initial Experience at a Single Center
- (2008) A. Nocera et al. TRANSPLANTATION PROCEEDINGS
- Living Donor Liver Transplantation for Hepatocellular Carcinoma in Patients Exceeding the UCSF Criteria
- (2008) I. Fouzas et al. TRANSPLANTATION PROCEEDINGS
- Long-Term Results After Liver Transplantation With “Livers That Nobody Wants” Within Eurotransplant: A Center's Experience
- (2008) G.C. Sotiropoulos et al. TRANSPLANTATION PROCEEDINGS
- Liver Transplantation as a Primary Indication for Intrahepatic Cholangiocarcinoma: A Single-Center Experience
- (2008) G.C. Sotiropoulos et al. TRANSPLANTATION PROCEEDINGS
- Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria
- (2008) J. Zhou et al. TRANSPLANTATION PROCEEDINGS
- Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002
- (2007) Abby B Siegel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma
- (2007) Andrew X. Zhu CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More